180 Life Sciences Corp. (ATNF): Price and Financial Metrics
ATNF Price/Volume Stats
| Current price | $1.18 | 52-week high | $17.75 |
| Prev. close | $1.17 | 52-week low | $0.66 |
| Day low | $1.10 | Volume | 128,600 |
| Day high | $1.27 | Avg. volume | 157,217 |
| 50-day MA | $1.01 | Dividend yield | N/A |
| 200-day MA | $1.80 | Market Cap | 6.72M |
ATNF Stock Price Chart Interactive Chart >
180 Life Sciences Corp. (ATNF) Company Bio
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and Anti-TNF platform, which focuses on fibrosis and anti-tumor necrosis factors; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Menlo Park, California.
ATNF Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -49.79% |
| 1-year | -25.32% |
| 3-year | -99.77% |
| 5-year | N/A |
| YTD | -35.16% |
| 2024 | -55.13% |
| 2023 | -93.70% |
| 2022 | -95.65% |
| 2021 | 42.86% |
| 2020 | N/A |
Loading social stream, please wait...